Bristol-Myers Squibb Company (BMY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Princeton, NJ, United States. Der aktuelle CEO ist Christopher S. Boerner.
BMY hat IPO-Datum 1972-06-01, 34,100 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $118.58B.
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, licenses, manufactures, and markets innovative medicines across multiple therapeutic areas including oncology, cardiovascular disease, immunology, hematology, and neuroscience. The company's leading portfolio includes blockbuster drugs such as Revlimid for multiple myeloma, Eliquis for stroke prevention and blood clots, Opdivo for cancer treatment, and Orencia for rheumatoid arthritis, along with numerous other specialty pharmaceuticals addressing serious diseases. Bristol-Myers Squibb distributes its products through wholesalers, distributors, pharmacies, retailers, hospitals, and government agencies worldwide. Founded in 1887 and headquartered in New York, the company has established itself as a major player in the global pharmaceutical industry with a strong emphasis on advancing patient care through targeted biological therapies.
